Biomarkers in patients with mucopolysaccharidosis type II and IV

被引：45

作者：

Fujitsuka, Honoka ^{[1
,2
]}

Sawamoto, Kazuki ^{[1
]}

Peracha, Hira ^{[1
,3
]}

Mason, Robert W. ^{[1
,3
]}

Mackenzie, William ^{[1
]}

Kobayashi, Hironori ^{[4
]}

Yamaguchi, Seiji ^{[4
]}

Suzuki, Yasuyuki ^{[2
]}

Orii, Kenji ^{[5
]}

Orii, Tadao ^{[5
]}

Fukao, Toshiyuki ^{[5
]}

Tomatsu, Shunji ^{[1
,4
,5
,6
]}

机构：

[1] Nemours Alfred I DuPont Hosp Children, Wilmington, DE 19899 USA

[2] Gifu Univ, Med Educ Dev Ctr, Gifu, Japan

[3] Univ Delaware, Dept Biol Sci, Newark, DE USA

[4] Shimane Univ, Dept Pediat, Matsue, Shimane, Japan

[5] Gifu Univ, Grad Sch Med, Dept Pediat, Gifu, Japan

[6] Thomas Jefferson Univ, Dept Pediat, Philadelphia, PA 19107 USA

来源：

MOLECULAR GENETICS AND METABOLISM REPORTS | 2019年 / 19卷

基金：

美国国家卫生研究院;

关键词：

Morquio syndrome; Hunter syndrome; Glycosaminoglycans; Cytokines; Inflammation; BONE-MARROW-TRANSPLANTATION; ENZYME REPLACEMENT THERAPY; STEM-CELL TRANSPLANTATION; KERATAN SULFATE; HEPARAN-SULFATE; MATRIX METALLOPROTEINASES; GLYCOSAMINOGLYCAN LEVELS; INFLAMMATORY CYTOKINES; TRACHEAL OBSTRUCTION; JOINT DISEASE;

D O I：

10.1016/j.ymgmr.2019.100455

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Glycosaminoglycans (GAGs), dermatan sulfate (DS), heparan sulfate (HS), and keratan sulfate (KS), are the primary biomarkers in patients with mucopolysaccharidoses (MPS); however, little is known about other biomarkers. To explore potential biomarkers and their correlation with GAGs, blood samples were collected from 46 MPS II patients, 34 MPS IVA patients, and 5 MPS IVB patients. We evaluated the levels of 8 pro-inflammatory factors (EGF, IL-1 beta, IL-6, MIP-1 alpha, TNF-alpha, MMP-1, MMP-2, and MMP-9), collagen type II, and DS, HS (HS0S, HSNS), and KS (mono-sulfated, di-sulfated) in blood. Eight biomarkers measured were significantly elevated in untreated MPS II patients, compared with those in normal controls: EGF, IL-1 beta, IL-6, HS0S, HSNS, DS, mono-sulfated KS, and di-sulfated KS. The same eight biomarkers remained elevated in ERT-treated patients. However, only three biomarkers remained elevated in post-HSCT MPS II patients: EGF, mono-sulfated KS, and di-sulfated KS. Post-HSCT patients with MPS II showed that IL-1 beta and IL-6 were normalized as HS and DS levels decreased. Eight biomarkers were significantly elevated in untreated MPS IVA patients: EGF, IL-1 beta, IL-6, MIP-1 alpha, MMP-9, HSNS, mono-sulfated KS, and di-sulfated KS, and four biomarkers were elevated in MPS IVA patients under ERT: IL-6, TNF-alpha, mono-sulfated KS, and di-sulfated KS. There was no reduction of KS in the ERT-treated MPS IVA patient, compared with untreated patients. Two biomarkers were significantly elevated in untreated MPS IVB patients: IL-6 and TNF-alpha. Reversely, collagen type II level was significantly decreased in untreated and ERT-treated MPS II patients and untreated MPS IVA patients. In conclusion, selected pro-inflammatory factors can be potential biomarkers in patients with MPS II and IV as well as GAGs levels.

引用

页数：9

共 57 条

[1]

Batzios SP, 2012, JIMD REP, V3, P59, DOI 10.1007/8904_2011_58

[2] Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA [J].

Chinen, Yasutsugu ;

Higa, Takeshi ;

Tomatsu, Shunji ;

Suzuki, Yasuyuki ;

Orii, Tadao ;

Hyakuna, Nobuyuki .

MOLECULAR GENETICS AND METABOLISM REPORTS, 2014, 1 :31-41

[3] A molecular and histological characterization of cartilage from patients with Morquio syndrome [J].

De Franceschi, L. ;

Roseti, L. ;

Desando, G. ;

Facchini, A. ;

Grigolo, B. .

OSTEOARTHRITIS AND CARTILAGE, 2007, 15 (11) :1311-1317

[4] Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III [J].

de Ruijter, Jessica ;

de Ru, Minke H. ;

Wagemans, Tom ;

Ijlst, Lodewijk ;

Lund, Allan M. ;

Orchard, Paul J. ;

Schaefer, G. Bradley ;

Wijburg, Frits A. ;

van Vlies, Naomi .

MOLECULAR GENETICS AND METABOLISM, 2012, 107 (04) :705-710

[5] Oxidative and nitrative stress and pro-inflammatory cytokines in Mucopolysaccharidosis type II patients: effect of long-term enzyme replacement therapy and relation with glycosaminoglycan accumulation [J].

Diaz Jacques, Carlos Eduardo ;

Donida, Bruna ;

Mescka, Caroline P. ;

Rodrigues, Daiane G. B. ;

Marchetti, Desiree P. ;

Bitencourt, Fernanda H. ;

Burin, Maira G. ;

de Souza, Carolina F. M. ;

Giugliani, Roberto ;

Vargas, Carmen Regla .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2016, 1862 (09) :1608-1616

[6]

Dinarello C. A., 1997, REV E, V8, P253, DOI DOI 10.1016/S1359-6101(97)00023-3

[7] Natural history of Morquio A patient with tracheal obstruction from birth to death [J].

Doherty, Caitlin ;

Averill, Lauren W. ;

Theroux, Mary ;

Mackenzie, William G. ;

Pizarro, Christian ;

Mason, Robert W. ;

Tomatsu, Shunji .

MOLECULAR GENETICS AND METABOLISM REPORTS, 2018, 14 :59-67

[8] Oxidative stress and inflammation in mucopolysaccharidosis type IVA patients treated with enzyme replacement therapy [J].

Donida, Bruna ;

Marchetti, Desiree P. ;

Biancini, Giovana B. ;

Deon, Marion ;

Manini, Paula R. ;

da Rosa, Helen T. ;

Moura, Dinara J. ;

Saffi, Jenifer ;

Bender, Fernanda ;

Burin, Maira G. ;

Coitinho, Adriana S. ;

Giugliani, Roberto ;

Vargas, Carmen Regla .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2015, 1852 (05) :1012-1019

[9] The Basic Science of Articular Cartilage: Structure, Composition, and Function [J].

Fox, Alice J. Sophia ;

Bedi, Asheesh ;

Rodeo, Scott A. .

SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH, 2009, 1 (06) :461-468

[10] Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA [J].

Hendriksz, C. J. ;

Harmatz, P. ;

Beck, M. ;

Jones, S. ;

Wood, T. ;

Lachman, R. ;

Gravance, C. G. ;

Orii, T. ;

Tomatsu, S. .

MOLECULAR GENETICS AND METABOLISM, 2013, 110 (1-2) :54-64

← 1 2 3 4 5 6 →